Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
35
Frequently Asked Questions
What is Market Cap of Emmaus Life Sciences Incorporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Emmaus Life Sciences Incorporation market cap is $710,500.00.
What is the 52-week high for Emmaus Life Sciences Incorporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Emmaus Life Sciences Incorporation 52 week high is $0.0499 as of September 13, 2025.
What is the 52-week low for Emmaus Life Sciences Incorporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Emmaus Life Sciences Incorporation 52 week low is $0.0039 as of September 13, 2025.
What is Emmaus Life Sciences Incorporation stock price today?
Emmaus Life Sciences Incorporation stock price today is $0.0111.
What was Emmaus Life Sciences Incorporation stock price yesterday?
Emmaus Life Sciences Incorporation stock price yesterday was $0.0109.
What is the PE ratio of Emmaus Life Sciences Incorporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Emmaus Life Sciences Incorporation’s P/E ratio is -0.16.
What is the Price-to-Book ratio of Emmaus Life Sciences Incorporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Emmaus Life Sciences Incorporation P/B ratio is -0.0128.
What is the 50-day moving average of Emmaus Life Sciences Incorporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Emmaus Life Sciences Incorporation 50-day moving average is $0.0133.
How many employess does Emmaus Life Sciences Incorporation has?
Emmaus Life Sciences Incorporation has 35 employees.